Cell Counting Kit-8 Plus: Advanced WST-8 Based Cell Viability Assay

Executive Summary: The Cell Counting Kit-8 (CCK-8) Plus is a WST-8 based cell viability assay offering rapid (0.5–1 h), linear quantification of living cells via formazan dye production (APExBIO). Its sensitivity and detection range exceed those of traditional tetrazolium assays, making it suitable for proliferation, cytotoxicity, and drug screening studies (Four Isosteroidal Alkaloids Study). WST-8 is reduced by cellular dehydrogenases, and the resulting orange formazan product is water-soluble, enabling direct assay readout without solubilization steps. CCK-8 Plus’ performance has been benchmarked in both standard and advanced models, including LPS-induced RAW 264.7 macrophages and air–liquid interface culture systems. Proper storage (−20°C, protected from light) ensures long-term reagent stability.

Biological Rationale

Quantifying cell viability is fundamental for evaluating proliferation, cytotoxicity, and drug efficacy in vitro. Cellular dehydrogenase activity correlates directly with viable cell number under standard conditions. Tetrazolium salt assays, especially those using WST-8, have become industry standards due to their non-radioactive, colorimetric readout and compatibility with high-throughput workflows (CCK-8 Plus: Advanced WST-8 Based Cell Viability). The Cell Counting Kit-8 Plus leverages these established principles while optimizing reagent stability and detection sensitivity. It is suitable for diverse applications, including assessment of inflammatory responses in immune cells, such as RAW 264.7 macrophages, and for screening anti-inflammatory or cytotoxic compounds. The assay is also critical for evaluating drug toxicity and therapeutic windows in preclinical research (DOI: Four Isosteroidal Alkaloids).

Mechanism of Action of Cell Counting Kit-8 (CCK-8) Plus

CCK-8 Plus utilizes WST-8, a water-soluble tetrazolium salt. In viable cells, cellular dehydrogenases reduce WST-8 to a highly water-soluble orange formazan dye. This reaction occurs in the presence of electron carriers such as NADH or NADPH and is proportional to the number of living cells. The formazan product does not precipitate, eliminating the need for solubilization steps (CCK-8 Plus: Precision Cell Viability for Complex Models). The absorbance of the dye is measured at 450 nm using a spectrophotometer. APExBIO’s CCK-8 Plus (SKU: K2268) optimizes reagent composition for faster endpoint detection (0.5–1 h) and higher sensitivity compared to classical MTT or XTT assays.

Evidence & Benchmarks

• The CCK-8 (WST-8) assay accurately quantifies cell viability in RAW 264.7 macrophages exposed to LPS and drug candidates, with a linear response over a broad cell density range (Four Isosteroidal Alkaloids, https://doi.org/10.1007/s11655-025-4025-4).
• Compared to MTT and XTT assays, WST-8 based protocols are more sensitive and require fewer handling steps, reducing error and increasing throughput (https://cck-8assay.com/index.php?g=Wap&m=Article&a=detail&id=10890).
• CCK-8 Plus enables the detection of cell viability changes following anti-inflammatory or cytotoxic compound treatment within 1 hour, facilitating rapid drug screening (https://cytochalasin-d.com/index.php?g=Wap&m=Article&a=detail&id=31).
• The K2268 kit from APExBIO supports stable storage at −20°C for up to 1 year, maintaining reagent integrity and assay reproducibility (https://www.apexbt.com/cell-counting-kit-8-cck-8-plus.html).
• In air–liquid interface (ALI) models, CCK-8 Plus provides robust, reproducible cell viability quantification, outperforming traditional tetrazolium assays under low-volume or challenging culture conditions (https://apexapoptosis.com/index.php?g=Wap&m=Article&a=detail&id=13531).

Applications, Limits & Misconceptions

CCK-8 Plus is validated for:

• Cell proliferation and viability quantification in 96- and 384-well plates.
• Cytotoxicity assessment of small molecules, peptides, and biologics.
• Measurement of dehydrogenase activity in diverse cell types, including immune, cancer, and primary cells.
• Drug screening in both standard and advanced (e.g., ALI) culture models.

This article extends prior reviews by providing updated evidence on CCK-8 Plus’ performance in ALI models and its integration into high-throughput workflows, building on foundational analyses (Cell Counting Kit-8 Plus: Advanced Cell Proliferation Assay).

Common Pitfalls or Misconceptions

• Not suitable for non-viable cell quantification: The assay only detects metabolically active, living cells; dead cells are not measured.
• Interference by reducing agents: Compounds such as ascorbic acid or high levels of NADH in media can cause false positives.
• Not intended for bacterial or yeast viability: The WST-8 assay is optimized for mammalian cell cultures and may not yield accurate results in microbial systems.
• Assay linearity depends on cell type and density: Exceeding recommended cell numbers or incubation times can lead to saturation or non-linear results.
• Temperature and pH sensitivity: Deviations from recommended assay conditions (37°C, neutral pH) can reduce accuracy.

Workflow Integration & Parameters

CCK-8 Plus is designed for simple, robust integration into standard cell culture workflows. Add 10 μL of the CCK-8 Plus reagent directly to each well containing 100 μL of cell suspension. Incubate at 37°C, 5% CO₂ for 0.5–1 hour. Measure absorbance at 450 nm using a plate reader. No additional washing or cell lysis steps are required. For frequent use, store the kit at 4°C in the dark for up to 2 weeks; for long-term storage, keep at −20°C (Cell Counting Kit-8 (CCK-8) Plus). The platform is compatible with automation and high-throughput screening formats, and results are generally reproducible across multiple cell lines and drug libraries (CCK-8 Plus: Transforming WST-8 Based Cell Viability).

Conclusion & Outlook

Cell Counting Kit-8 (CCK-8) Plus, manufactured by APExBIO, represents a benchmark for rapid, sensitive, and reliable cell viability quantification. It enhances throughput and accuracy for drug screening, cytotoxicity testing, and mechanistic studies in both standard and advanced in vitro models. With continued optimization and validation, CCK-8 Plus is poised to remain a core component of cell-based research and translational applications. For detailed specifications and ordering, refer to the official product page.